Neuroloxía Experimental da Enfermidade de Parkinson
Publicacións (365) Publicacións nas que participase algún/ha investigador/a
2024
-
Angiotensin type 1 receptor activation promotes neuronal and glial alpha-synuclein aggregation and transmission
npj Parkinson's Disease, Vol. 10, Núm. 1
-
Biodistribution and pharmacokinetics of [89Zr]-anti-VEGF mAbs using PET in glioblastoma rat models
International Journal of Pharmaceutics, Vol. 652
-
Hypothalamic free fatty acid receptor-1 regulates whole-body energy balance
Molecular Metabolism, Vol. 79
-
Incidence and causes of hospitalization in patients with transthyretin (ATTR-CA) and light chain (AL-CA) cardiac amyloidosis
Medicina Clinica, Vol. 162, Núm. 7, pp. e1-e7
-
Inflammatory bowel disease induces pathological α-synuclein aggregation in the human gut and brain
Neuropathology and Applied Neurobiology, Vol. 50, Núm. 1
-
Non-HLA angiotensin-type-1 receptor autoantibodies mediate the long-term loss of grafted neurons in Parkinson’s disease models
Stem Cell Research and Therapy, Vol. 15, Núm. 1
-
Prognostic value of the tricuspid annular plane systolic excursion/systolic pulmonary artery pressure ratio in cardiac amyloidosis
Revista Espanola de Cardiologia
-
The role of the brain renin-angiotensin system in Parkinson´s disease
Translational Neurodegeneration, Vol. 13, Núm. 1
2023
-
A randomized clinical trial of candesartan for cognitive impairment in Parkinson's disease
Parkinsonism and Related Disorders, Vol. 110
-
AT1 receptor autoantibodies mediate effects of metabolic syndrome on dopaminergic vulnerability
Brain, Behavior, and Immunity, Vol. 108, pp. 255-268
-
Astrocytic insulin receptor controls circadian behavior via dopamine signaling in a sexually dimorphic manner
Nature Communications, Vol. 14, Núm. 1
-
Boolean analysis shows a high proportion of dopamine D2 receptors interacting with adenosine A2A receptors in striatal medium spiny neurons of mouse and non-human primate models of Parkinson's disease
Neurobiology of Disease, Vol. 188
-
Cognitive impairment and dementia in young onset Parkinson’s disease
Journal of Neurology, Vol. 270, Núm. 12, pp. 5793-5812
-
Combined cell-based therapy strategies for the treatment of Parkinson's disease: Focus on mesenchymal stromal cells
Neural Regeneration Research, Vol. 18, Núm. 3, pp. 478-484
-
Epidemiology of ataxia and hereditary spastic paraplegia in Spain: a cross-sectional study
Neurologia, Vol. 38, Núm. 6, pp. 379-386
-
Extracellular Vesicles and Their Renin–Angiotensin Cargo as a Link between Metabolic Syndrome and Parkinson’s Disease
Antioxidants, Vol. 12, Núm. 12
-
Falls Predict Acute Hospitalization in Parkinson's Disease
Journal of Parkinson's disease, Vol. 13, Núm. 1, pp. 105-124
-
Interactions between Angiotensin Type-1 Antagonists, Statins, and ROCK Inhibitors in a Rat Model of L-DOPA-Induced Dyskinesia
Antioxidants, Vol. 12, Núm. 7
-
Neuromelanin accumulation drives endogenous synucleinopathy in non-human primates
Brain : a journal of neurology, Vol. 146, Núm. 12, pp. 5000-5014
-
Ringworm by Nannizzia nana: Clinical case and literature review
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 8, pp. 501-504